Showing results (61-70 of 739) with videos related to
Sort By:
Pageof 74
The Journal of Rheumatology|April 17, 2004
A double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the kneeRichard Day, Peter Brooks, Philip G Conaghan, et al.BMC Musculoskeletal Disorders|February 2, 2022
Impact of tanezumab on health status, non-work activities and work productivity in adults with moderate-to-severe osteoarthritisPhilip G Conaghan, Lucy Abraham, Lars Viktrup, et al.Evidence-Based Medicine|September 4, 2017
Quality of reporting of harms in randomised controlled trials of pharmacological interventions for rheumatoid arthritis: a systematic reviewMuhammad Abdul Hadi, Gretl A McHugh, Philip G ConaghanBest Practice & Research. Clinical Rheumatology|December 25, 2015
Monitoring in established RA: Role of imaging and soluble biomarkersJoshua F Baker, York Kiat Tan, Philip G ConaghanCurrent Pharmaceutical Design|March 12, 2015
Biological therapies in osteoarthritisClaire Y J Wenham, Michael McDermott, Philip G ConaghanOsteoarthritis and Cartilage|March 4, 2026
Digital mobility measures in osteoarthritis: endpoint innovation without losing what mattersRobin Christensen, Philip Rask Lage-Hansen, Philip G ConaghanRheumatic Diseases Clinics of North America|July 7, 2019
Should Methotrexate Have Any Place in the Treatment of Psoriatic Arthritis?Weiyu Ye, Laura C CoatesMusculoskeletal Care|November 10, 2022
Outcome measures in psoriatic arthritis: Where next?Simon Hackett, Laura C CoatesThe Journal of Rheumatology|July 7, 2023
Is Axial Psoriatic Arthritis the Same as Ankylosing Spondylitis With Psoriasis: A DebateLaura C Coates, Atul DeodharRheumatology (Oxford, England)|March 12, 2020
Assessment of the many faces of PsA: single and composite measures in PsA clinical trialsDylan McGagh, Laura C CoatesPageof 74